Cigna Group $CI Shares Purchased by V Square Quantitative Management LLC

V Square Quantitative Management LLC lifted its stake in Cigna Group (NYSE:CIFree Report) by 2.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,480 shares of the health services provider’s stock after purchasing an additional 124 shares during the quarter. V Square Quantitative Management LLC’s holdings in Cigna Group were worth $2,142,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its stake in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Cigna Group by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after acquiring an additional 98,715 shares during the last quarter. Dodge & Cox increased its stake in Cigna Group by 1.3% during the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after acquiring an additional 117,125 shares during the last quarter. GQG Partners LLC increased its stake in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Parnassus Investments LLC increased its stake in Cigna Group by 3.1% during the first quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider’s stock worth $949,357,000 after acquiring an additional 86,602 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Guggenheim restated a “buy” rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Truist Financial set a $375.00 price target on Cigna Group in a research report on Tuesday, September 2nd. Finally, Robert W. Baird set a $372.00 price target on Cigna Group in a research report on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of “Buy” and a consensus target price of $371.81.

Get Our Latest Research Report on Cigna Group

Cigna Group Trading Up 0.7%

NYSE:CI opened at $286.04 on Monday. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The firm has a market cap of $76.35 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 0.84 and a beta of 0.48. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average price of $292.71 and a 200 day moving average price of $310.49.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the previous year, the firm posted $6.72 EPS. Cigna Group’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is presently 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.